The Oedematous Mr H - PowerPoint PPT Presentation

1 / 29
About This Presentation
Title:

The Oedematous Mr H

Description:

... causes: goitre, aortic aneurysm and granulomatous infection secondary ... comorbid conditions such as tuberculosis, histoplasmosis, or aortic aneurysm. ... – PowerPoint PPT presentation

Number of Views:84
Avg rating:3.0/5.0
Slides: 30
Provided by: resourc9
Category:

less

Transcript and Presenter's Notes

Title: The Oedematous Mr H


1
The Oedematous Mr H
Student Grand Round 09.12.2003
The Oedematous Mr H
Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
2
The Oedematous Mr H
HISTORY
  • Mr H 58 yr old taxi driver
  • PC
  • 3/12 Hx persistent productive cough, with yellow
    sputum production
  • HPC
  • Abx relieved symptoms initially, however cough
    returned coinciding with flu jab
  • Pt was sent for CXR subsequently referred to
    Rapid Access Chest Clinic
  • Symptoms/ signs on presentation
  • Cough and sputum production
  • 7 kg weight loss over 3/12
  • Fatigue over 2/52, which has stopped Pt working
  • Difficulty swallowing solids over 3-4/52
  • 6/7 Hx facial swelling mild headache
  • SOB
  • Worsens at night, but no orthopnea (sleeps with
    2 pillows)
  • Onset after walking 100 yards

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
3
The Oedematous Mr H
HISTORY
  • PMH
  • Rheumatic fever as a child
  • Early 1980s Frozen shoulder, treated
    conservatively
  • Mid 1980s
  • Dx Diabetes Mellitus Type II following 1yr Hx
    paraesthesia on dorsal aspect of both feet
  • Blood tests also highlighted some degree of
    liver dysfunction, managed conservatively Pt ?
    alcohol intake
  • August 1999 MI
  • May 2000 MI
  • Angina drug managed
  • Stress headaches
  • ºAllergies
  • DH
  • Lanspoprazole 30mg od
  • Asprin 75mg od
  • Isosorbide Mononitrate 10mg bd
  • GTN spray
  • Fenofibrate 267mg od

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
4
The Oedematous Mr H
HISTORY
  • SE
  • CVS - Angina (drug managed), nil of note
  • Resp - Difficulty with full inspiration
    taking a full deep breath in
  • GI - ? appetite
  • - Weight loss since onset of cough
  • GU - nil of note
  • MSS - nil of note
  • CNS - Peripheral neuropathy 2º to Diabetes
  • THREADS

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
5
The Oedematous Mr H
HISTORY
  • FH
  • Two sons one daughter (1st marriage).
  • Now remarried, with one step son.
  • Significant FHx Diabetes Heart Failure on
    mothers side.
  • Father died aged 64 of lung Ca, mother died in
    late 80s of Heart Failure.
  • SH
  • Lives with 2nd wife, in 4th floor flat in
    Clapham.
  • Flat does have lift but Pt likes to walk where
    possible.
  • No problems with ADL.
  • Smoked 20/day for 50years currently trying to
    stop but has had many previous failed quit
    attempts.
  • Drinks 5-6pints/wk, but previous Hx v heavy
    drinking (14 bottles whiskey/wk).

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
6
The Oedematous Mr H
OBSERVATIONS EXAMINATION
  • Obs
  • PR - 85
  • RR - 20
  • BP - 130/80
  • Temp - 36C
  • BM - 6.6
  • General - Facial swelling and significant
    periorbital oedema
  • Large palpable R cervical LN, palpable
    axillary LN
  • Nicotine stained hands
  • CVS - NAD
  • Resp - Bronchial breathing RUL posteriorly with
    decreased air entry.
  • GI - No palpable masses, liver, kidneys or
    spleen.
  • Neuro - NAD
  • JACCOL

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
7
The Oedematous Mr H
SUMMARY AND IMPRESSION
  • Summary
  • Mr H is a 58 year old taxi driver
  • Presented with Hx cough SOB over 3/12
  • O/E Bronchial breathing RUL posteriorly with ?
    air entry and palpable R cervical LN
  • Co-morbidity Diabetes mellitus and ischaemic
    heart disease
  • Has a 50 pack year history and has been a heavy
    drinker
  • Clinical impression prior to any Ix
  • Probable bronchial Ca, with cervical LN
    involvement and Superior Vena Cava Obstruction
    (SVCO)
  • Chronic infection
  • Plan
  • Admit Pt
  • FNA of cervical LN to determine histology

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
8
The Oedematous Mr H
MANAGEMENT
  • Admitted to ward under c/o Dr Rees
  • Immediate management 8mg of dexamethasone b.d.
  • Further tests
  • CXR
  • Blood test
  • FNA cervical LN- SCLC confirmed by other
    histological tests
  • CT scan thorax and abdomen
  • Bone scan

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
9
The Oedematous Mr H
CXR
Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
10
The Oedematous Mr H
CT 1
Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
11
The Oedematous Mr H
CT 2
Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
12
The Oedematous Mr H
BONE SCAN
Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
13
The Oedematous Mr H
MANAGEMENT
  • 21/11
  • Started on chemotherapy etoposide 100mg b.d.
  • 23/11
  • Generally well
  • Stable
  • Symptoms improved
  • Discharged

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
14
The Oedematous Mr H
LUNG CANCER
  • Most common cause of cancer death worldwide.
  • Malesgtgtfemales.

Risk factors
  • Un-modifiable
  • Gender
  • Race
  • Genetic predisposition
  • Modifiable
  • Smoking
  • Passive smoking
  • Pollution
  • Exposure to occupational carcinogens
  • Diet

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
15
The Oedematous Mr H
SMALL CELL LUNG CANCER
  • 15-20 of all lung ca
  • Central/hilar tumours which arise from
    Kulchitsky cells
  • Rapid onset
  • Aggressive course
  • Widespread metastasis
  • Extremely sensitive to chemotherapy
    radiotherapy

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
16
The Oedematous Mr H
SCLC
  • Symptoms
  • Cough
  • Chest pain
  • Haemoptypsis
  • Wheezing
  • Anorexia
  • Weight loss
  • Distant spread
  • No symptoms
  • Signs
  • Reduced BS
  • Dullness to percussion
  • Hepatomegaly
  • Lymphadenopathy
  • Clubbing
  • SVCO
  • Paraneoplastic syndromes in SCLC
  • SIADH
  • Ectopic Cushing's
  • Rare neurological syndromes

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
17
The Oedematous Mr H
SCLC
  • Investigations
  • CXR
  • FBC
  • UE
  • Bone scan
  • CT (to include liver adrenals)
  • LFTs

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
18
The Oedematous Mr H
SCLC
  • Treatment
  • Surgery - limited in value except in limited
    stage disease.
  • Radiation - limited as curative, but useful in
    prophylaxis or as palliative treatment.
  • Chemotherapy - combination therapy better than
    single agent therapy, standard combinations CDV,
    PE, CAVE, alternating EP and CAV
  • Palliative treatment - for progressive
    non-curable SCLC.

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
19
The Oedematous Mr H
SUPERIOR VENA CAVA SYNDROME
  • Occurs when the vena cava is occluded.
  • Obstruction - External (e.g. tumour,
    lymphadenopathy)
  • - Intra-luminal (e.g. tumour, thrombosis).
  • Malignancy ? 90 of SVCS cases. SVCS poor
    prognostic indicator.
  • Advanced lung cancer, specifically small cell
    carcinoma (SCLC), accounts for 75 of malignant
    SVCS causes.
  • Other malignant causes Non-Hodgkins (and more
    rarely, Hodgkins) lymphoma, and mediastinal
    metastases from Breast Ca, Kaposis sarcoma,
    thymoma, fibrous mesothelioma and germ cell
    cancers.
  • Non malignant causes goitre, aortic aneurysm
    and granulomatous infection secondary to TB.
  • Iatrogenic causes venous thrombosis due to
    central line fibrosis due to mediastinum
    radiotherapy.

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
20
The Oedematous Mr H
SUPERIOR VENA CAVA SYNDROME
Patients with cancer at increased risk of SVCS
  • Patients with small cell lung cancer or, less
    frequently, non-small cell lung carcinoma (e.g.
    squamous cell carcinoma) and those with right
    lung involvement.
  • Patients with non-Hodgkins lymphoma.
  • Male patients aged 50-70 years who have primary
    or metastatic tumours of the mediastinum.
  • Patients with breast carcinoma and mediastinal
    metastasis, Kaposis sarcoma with mediastinal
    involvement, thymoma, fibrous mesothelioma, and
    germ cell neoplasms.
  • Patients with central venous catheters and
    pacemaker catheters.
  • Patients who have received previous radiation
    therapy to the mediastinum.
  • Patients with cancer who have comorbid conditions
    such as tuberculosis, histoplasmosis, or aortic
    aneurysm.

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
21
The Oedematous Mr H
SUPERIOR VENA CAVA SYNDROME
  • Common presenting symptoms of SVCS
  • Dyspnoea (most common symptom) and
    non-productive cough.
  • Swelling of the face, arms, fingers, or neck
    (usually the first sign, often subtle).
  • Feeling of fullness of the head.
  • Difficulty buttoning shirt collars (Stoke's
    sign) women also may experience breast swelling.
  • Dysphagia and hoarseness.
  • Chest pain.
  • Later symptoms that may occur include
  • Life-threatening symptoms of respiratory
    distress, such as orthopnoea.
  • Headache, visual disturbances, dizziness, and
    syncope.
  • Lethargy, irritability, and mental status
    changes.

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
22
The Oedematous Mr H
SUPERIOR VENA CAVA SYNDROME
  • Common clinical signs elicited on examination
  • Oedema of the face, neck, upper thorax, breasts,
    and upper extremities.
  • Prominent venous pattern (i.e., dilated veins of
    face, neck, and thorax).
  • Jugular vein distension.
  • Periorbital oedema and redness and oedema of
    conjunctivae.
  • Facial plethora (ruddy complexion of face or
    cheeks).
  • Compensatory tachycardia.
  • Clinical signs indicating progression of SVCS
  • Cyanosis of the face or upper torso.
  • Engorged conjunctivae.
  • Mental status changes.
  • Tachypnoea, orthopnoea, stridor, and respiratory
    distress.
  • Stupor, coma, seizure, and death.

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
23
The Oedematous Mr H
SUPERIOR VENA CAVA SYNDROME
1. Dilated veins on neck and chest.
3. Oedema and conjunctival haemorrhage.
2. Jugular engorgement.
5. Tongue angiomata.
4. Suffused (flushed) face.
Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
24
The Oedematous Mr H
SUPERIOR VENA CAVA SYNDROME
  • Diagnosis concerned with identifying cause of
    SVCS
  • Identify obstruction of SVCS ? CXR and trunk CT.
  • History indicative of diseases previously
    mentioned directly (e.g. lung cancer) or via risk
    factors (e.g. heavy smoker) ? carry out
    appropriate investigations.
  • Dx Lung cancer ? sputum cytology lymph node
    biopsy/FNA histology.
  • Aims
  • Relief of SVC obstruction.
  • Restoration of normal SVC flow and/or
    development of collateral pathways of venous
    blood flow.
  • Relief of oedema and associated symptoms.
  • Cure, halt or slow progression of underlying
    pathology.

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
25
The Oedematous Mr H
SUPERIOR VENA CAVA SYNDROME
  • Management
  • Dyspnoea Elevate head of bed, provide O2.
  • IV access ? flow rate in upper thorax, arms
    and head contra-indicated for venepuncture and
    IV. Central line required.
  • Fluid Fluid and electrolyte balance should be
    monitored as over-hydration may exacerbate the
    symptoms. Diuretic use also monitored.
  • Blood pressure Compression on the upper arm
    from BP cuff avoided.
  • Side-effects of treatment Treatment has
    multiple diverse side-effects. Many of these
    side-effects may be more uncomfortable than the
    patients own experience of SVCS. Symptomatic
    relief ? treatments more bearable.

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
26
The Oedematous Mr H
SUPERIOR VENA CAVA SYNDROME
  • Treatment
  • Pharmacotherapy
  • Corticosteroids (prednisolone or dexamethasone)
    and diuretics used to reduce oedematous swelling,
    inflammation and fluid load.
  • Thrombolysis in obstruction of SVC by thrombus.
  • Anticoagulant therapy to deter
    malignancy-induced thrombus is controversial.
  • Radiotherapy
  • Local treatment of non-small cell lung and other
    malignancies.
  • Symptom relief 85-90 patients within 3/52.
  • Radiotherapy vs chemotherapy in ? SVCS symptoms
    is controversial.
  • Chemotherapy
  • Local and systemic treatment of malignancies.
  • Most common regimen for small cell lung cancer
    is a platinum-based compound (cisplatin,
    carboplatin) with etoposide.
  • Relief of symptoms usually occurs within 7-14
    days in most patients.
  • Surgery
  • SVC stent insertion or bypass are occasional
    interventions.
  • Secondary to other modalities.

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
27
The Oedematous Mr H
SUPERIOR VENA CAVA SYNDROME
  • Cochrane review
  • Radiotherapy chemotherapy VS surgical stent
    insertion VS steroids.
  • SVCS present at diagnosis in 10 patients with
    SCLC (small cell lung carcinoma) and 1.7 NSCLC
    (non small cell lung carcinoma).
  • SCLC - chemotherapy and/or radiotherapy symptom
    relief - 77.
  • - recurrence rate - 17.
  • NSCLC - chemotherapy and/or radiotherapy symptom
    relief - 60.
  • - recurrence rate - 19.
  • Stent insertion relieved symptoms in 95, with a
    recurrence rate of 11.
  • Rate of symptom relief was greater than other
    modalities.
  • Primary treatment option, or best-suited for
    treatment resistant cases?
  • Not sufficient evidence concerning steroids.

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
28
The Oedematous Mr H
SUPERIOR VENA CAVA SYNDROME
  • Outcome
  • Dependent upon prognostic factors of underlying
    pathology.
  • Radiotherapy with chemotherapy - 50-90
    effective in ? SVCS.
  • Evidence of ? effectiveness utilising both
    modalities if disease not responsive to either
    given alone.
  • 70 treated remain SVCS-free prior to death.
  • Recurrence of SVCS after initial treatment ?
    poor prognosis.
  • Severity and outcome of SVCS not good predictors
    of underlying pathology (e.g. tumour size,
    thrombus resolution).

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
29
The Oedematous Mr H
END OF PRESENTATION
  • Questions?

Student Grand Round 09.12.2003 - Dr Rees Firm
C. Tucker, I. Rajkomar R. Green
Write a Comment
User Comments (0)
About PowerShow.com